The Bombay High Court upheld restrictions on The New Indian Express using the brand name beyond agreed territorial limits under a family settlement. The Court dismissed EPM’s appeal and reaffirmed The Indian Express’s trademark and brand rights.
The Bombay High Court ruled in favour of Sun Pharma in a trademark dispute over Pantocid. The court restrained Zawadi Healthcare from using Pantozed, citing risk of confusion in medicines.
Cross Border IP Protection has become essential for Indian innovators as their businesses expand globally and face rising competition across markets. Without a strong international strategy, they risk infringement, loss of exclusivity, and reduced commercial value abroad too.
The Delhi High Court protected Sonakshi Sinha’s personality rights, barring unauthorized use of her image, voice or likeness by platforms including AI chatbots, prohibiting merchandise sales, and directing removal of infringing links within 36 hours.
The Delhi High Court restrained “American Dream11” from using Dream11’s mark and ordered removal of all related social media pages. The Court also referred the trademark dispute to mediation scheduled for November 17.
